These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38960709)

  • 1. Amyloid-β as a Key Player in Cerebrovascular Dysfunction in Alzheimer's Disease.
    Stelzer GT; Lima-Filho RAS
    J Neurosci; 2024 Jul; 44(27):. PubMed ID: 38960709
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta.
    Park L; Wang G; Zhou P; Zhou J; Pitstick R; Previti ML; Younkin L; Younkin SG; Van Nostrand WE; Cho S; Anrather J; Carlson GA; Iadecola C
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5063-8. PubMed ID: 21383152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
    Brenner SR
    Neurology; 2008 Jan; 70(3):243-4. PubMed ID: 18195273
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between cerebrovascular disease and Alzheimer pathology.
    Saito S; Ihara M
    Curr Opin Psychiatry; 2016 Mar; 29(2):168-73. PubMed ID: 26779861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.
    Price JM; Chi X; Hellermann G; Sutton ET
    Neurol Res; 2001 Jul; 23(5):506-12. PubMed ID: 11474807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).
    Yang H; Hou T; Wang W; Luo Y; Yan F; Jia J
    J Alzheimers Dis; 2018; 62(4):1609-1621. PubMed ID: 29614686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.
    Kalaria RN
    Neurobiol Aging; 2009 Sep; 30(9):1512-4. PubMed ID: 18187235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia.
    Iadecola C
    Cell Mol Neurobiol; 2003 Oct; 23(4-5):681-9. PubMed ID: 14514024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats.
    de la Torre JC; Pappas BA; Prevot V; Emmerling MR; Mantione K; Fortin T; Watson MD; Stefano GB
    Neurol Res; 2003 Sep; 25(6):635-41. PubMed ID: 14503018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
    Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
    Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.
    Honjo K; Black SE; Verhoeff NP
    Can J Neurol Sci; 2012 Nov; 39(6):712-28. PubMed ID: 23227576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular disorders caused by hyperfibrinogenaemia.
    Muradashvili N; Tyagi R; Tyagi N; Tyagi SC; Lominadze D
    J Physiol; 2016 Oct; 594(20):5941-5957. PubMed ID: 27121987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's dementia by circulation disorders: when trees hide the forest.
    Dotti CG; De Strooper B
    Nat Cell Biol; 2009 Feb; 11(2):114-6. PubMed ID: 19188916
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
    Sagare AP; Bell RD; Zlokovic BV
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A beta, aging, and Alzheimer's disease: a tale, models, and hypotheses.
    Chaney MO; Baudry J; Esh C; Childress J; Luehrs DC; Kokjohn TA; Roher AE
    Neurol Res; 2003 Sep; 25(6):581-9. PubMed ID: 14503011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer's Disease.
    Dong S; Maniar S; Manole MD; Sun D
    Transl Stroke Res; 2018 Jun; 9(3):238-250. PubMed ID: 28971348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of amyloid-beta by circulating lipoprotein receptors.
    Sagare A; Deane R; Bell RD; Johnson B; Hamm K; Pendu R; Marky A; Lenting PJ; Wu Z; Zarcone T; Goate A; Mayo K; Perlmutter D; Coma M; Zhong Z; Zlokovic BV
    Nat Med; 2007 Sep; 13(9):1029-31. PubMed ID: 17694066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.